Back to Search Start Over

Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations.

Authors :
Khedri M
Maleki R
Dahri M
Sadeghi MM
Rezvantalab S
Santos HA
Shahbazi MA
Source :
Drug delivery and translational research [Drug Deliv Transl Res] 2022 Jun; Vol. 12 (6), pp. 1408-1422. Date of Electronic Publication: 2021 Sep 03.
Publication Year :
2022

Abstract

In late 2019, coronavirus disease 2019 (COVID-19) was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Spike protein is one of the surface proteins of SARS-CoV-2 that is essential for its infectious function. Therefore, it received lots of attention for the preparation of antiviral drugs, vaccines, and diagnostic tools. In the current study, we use computational methods of chemistry and biology to study the interaction between spike protein and its receptor in the body, angiotensin-I-converting enzyme-2 (ACE2). Additionally, the possible interaction of two-dimensional (2D) nanomaterials, including graphene, bismuthene, phosphorene, p-doped graphene, and functionalized p-doped graphene, with spike protein is investigated. The functionalized p-doped graphene nanomaterials were found to interfere with spike protein better than the other tested nanomaterials. In addition, the interaction of the proposed nanomaterials with the main protease (M <superscript>pro</superscript> ) of SARS-CoV-2 was studied. Functionalized p-doped graphene nanomaterials showed more capacity to prevent the activity of M <superscript>pro</superscript> . These 2D nanomaterials efficiently reduce the transmissibility and infectivity of SARS-CoV-2 by both the deformation of the spike protein and inhibiting the M <superscript>pro</superscript> . The results suggest the potential use of 2D nanomaterials in a variety of prophylactic approaches, such as masks or surface coatings, and would deserve further studies in the coming years.<br /> (© 2021. The Author(s).)

Details

Language :
English
ISSN :
2190-3948
Volume :
12
Issue :
6
Database :
MEDLINE
Journal :
Drug delivery and translational research
Publication Type :
Academic Journal
Accession number :
34476766
Full Text :
https://doi.org/10.1007/s13346-021-01054-w